Fixed combination of rivaroxaban and Aspirin: Tablet formulation and analytical method validation

Fixed combination of rivaroxaban and Aspirin: Tablet formulation and analytical method validation

Rivaroxaban and aspirin are commonly used antithrombotic agents in combination to prevent coronary artery disease (CAD) and atherothrombotic events in adult patients after acute coronary syndrome (ACS) with elevated cardiac biomarkers, or with coronary artery disease (CAD) or symptomatic peripheral...

Full description

Bibliographic Details
Main Authors: Hani Naseef, Mosab Afaneh, Moammal Qurt, Abdullah Rabba, Abdallah Abukhalil, Numan Malkieh, Maher Kharouf, Ramzi Moqadi
Format: Article
Language:English
Published: Elsevier 2024-08-01
Series:Talanta Open
Subjects:
Rivaroxaban
Aspirin
Fixed-dose combination
Validation
Rp HPLC method
Online Access:http://www.sciencedirect.com/science/article/pii/S2666831924000122

Internet

http://www.sciencedirect.com/science/article/pii/S2666831924000122

Similar Items